PlainRecalls
FDA Devices Moderate Class II Ongoing

Trevo ProVue, Catalog: 90184

Reported: June 5, 2024 Initiated: April 23, 2024 #Z-1903-2024

Product Description

Trevo ProVue, Catalog: 90184

Reason for Recall

Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.

Details

Recalling Firm
Stryker Neurovascular
Units Affected
280
Distribution
Worldwide - US Nationwide distribution including in the states of MN, PA, IL, AK, NY, CA, MI, WI, TX, AZ, FL, KY, MA, IN, NE, MT, CT, NJ, TN, VA, AL, CO, DE, OH, UT, NC, ME, GA, SC, GU, WA, MO, OR, DC, OK, LA, MD, ID, NH, SD, NV, RI, ND, HI, MS, AR, IA, NM, VT, KS and the countries of Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, SAR China, Hungary, India, Ireland, Israel, Italy, Japan, Korea (South), Lithuania, Luxembourg, Netherlands, Northern Ireland, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan, Republic of China, Thailand, Turkey, United Arab Emirates, United Kingdom.
Location
Fremont, CA

Frequently Asked Questions

What product was recalled?
Trevo ProVue, Catalog: 90184. Recalled by Stryker Neurovascular. Units affected: 280.
Why was this product recalled?
Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 5, 2024. Severity: Moderate. Recall number: Z-1903-2024.